Mark Cuban Value Plus Drug Corporate (MCCPDC) introduced it’s running with Coherus Biosciences, Inc. to promote Yusimry, a biosimilar model of the top-selling drug Humira, at a reduced value.
Yusimry is used to regard a number of sicknesses, reminiscent of rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, ulcerative colitis, hidradenitis suppurativa, Crohn’s illness and plaque psoriasis.
The drugs might be to be had thru MCCPDC beginning July 2023, costing $569.27 plus allotting and transport charges. It is going to be the primary biologic product introduced via the cut price drug provider.
In February, MCCPDC introduced a brand new program on Twitter, aiming to create an impartial pharmacists’ community the place individuals could be supplied a “Crew Cuban Advantages Card.” MCCPDC mentioned in a observation that Yusimry could be integrated in the advantages program thru taking part pharmacies.
“Coherus’s Yusimry is a sport changer. Having an alternative choice to Humira this is inexpensive will strengthen the lives of sufferers in every single place. Costplusdrugs.com is really excited to make Yusimry to be had to everybody in a clear approach,” Mark Cuban instructed MobiHealthNews in an e-mail.
THE LARGER TREND
Since MCCPDC’s release in 2022, it is evolved a large number of partnerships and collaborations.
In April, the corporate introduced a collaboration with Seattle-based Zócalo Well being, a digital healthcare carrier for Latino sufferers, to amplify Zócalo individuals’ get right of entry to to lower-cost prescription drugs.
That very same month, Fierce Healthcare reported MCCPDC teamed up with RevSpring, a well being cost answers corporate, to run a program with U.S. pharmacies to make medicine extra inexpensive for customers.
MCCPDC has additionally established partnerships with California-based EmsanaRx and Tennessee-based RxPreferred Advantages and introduced collaborations with diabetes and persistent illness control corporate Diathrive Well being and most cancers care reinforce corporate OncoPower.
MCCPDC was once additionally built-in into Rightway Well being‘s platform, permitting the drugstore receive advantages supervisor’s individuals get right of entry to to MCCPDC.
Final yr, the corporate additionally introduced its first well being plan partnership with Capital Blue Move, noting Capital’s individuals may just use their insurance coverage playing cards at MCCPDC without delay as of the beginning of 2023.